Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
The Laryngoscope|June 19, 2013
Biomarkers in advanced larynx cancerCarol R Bradford, Bhavna Kumar, Emily Bellile, et al.
The Oncologist|May 31, 2022
Long-term Outcomes with Nivolumab as First-line Treatment in Recurrent or Metastatic Head and Neck Cancer: Subgroup Analysis of CheckMate 141Maura L Gillison, George Blumenschein, Jerome Fayette, et al.
Thyroid : Official Journal of the American Thyroid Association|August 11, 2022
Multikinase Inhibitors for the Treatment of Asymptomatic Radioactive Iodine-Refractory Differentiated Thyroid Cancer: Global Noninterventional Study (RIFTOS MKI)Marcia S Brose, Johannes W A Smit, Chia-Chi Lin, et al.
The Oncologist|June 6, 2018
CheckMate 141: 1-Year Update and Subgroup Analysis of Nivolumab as First-Line Therapy in Patients with Recurrent/Metastatic Head and Neck CancerMaura L Gillison, George Blumenschein, Jerome Fayette, et al.
Oral Oncology|June 10, 2018
Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expressionRobert L Ferris, George Blumenschein, Jerome Fayette, et al.
Head & Neck|April 29, 2024
Follow-up for human papillomavirus-related oropharynx cancer concentrated on unequal symptom change (FOCUS): Prospective patient-reported outcome collectionDonna M Edwards, Laila A Gharzai, Weilin Wang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 29, 2020
Invasive squamous cell carcinomas and precursor lesions on UV-exposed epithelia demonstrate concordant genomic complexity in driver genesLorena Lazo de la Vega, Nolan Bick, Kevin Hu, et al.
Clinical and Translational Radiation Oncology|January 13, 2022
Imaging response assessment for predicting outcomes after bioselection chemotherapy in larynx cancer: A secondary analysis of two prospective trialsLaila A Gharzai, Julia Pakela, Elizabeth M Jaworski, et al.
The New England Journal of Medicine|October 11, 2016
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and NeckRobert L Ferris, George Blumenschein, Jerome Fayette, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|March 21, 2020
Predictors of survival in patients undergoing oropharyngeal surgery for cancer recurrence after radiation therapyMolly E Heft Neal, Julia Brennan, Catherine T Haring, et al.
Pageof 7